Johnson & Johnson (JNJ) News Today → Don’t buy a single NVIDIA share before you see this... (From Behind the Markets) (Ad) Free JNJ Stock Alerts $146.67 +1.39 (+0.96%) (As of 05/31/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative June 1 at 2:52 PM | marketbeat.comJohnson & Johnson (NYSE:JNJ) Stake Raised by Brown Brothers Harriman & Co.Brown Brothers Harriman & Co. boosted its holdings in Johnson & Johnson (NYSE:JNJ - Free Report) by 5.8% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 384,776 shares of the company's stocJune 1 at 6:12 AM | americanbankingnews.comJohnson & Johnson (NYSE:JNJ) Now Covered by The Goldman Sachs GroupJune 1 at 5:50 AM | fool.com3 Magnificent Dividend Stocks to Buy and Hold ForeverJune 1 at 1:54 AM | americanbankingnews.comJohnson & Johnson (NYSE:JNJ) Receives Consensus Recommendation of "Hold" from BrokeragesMay 31 at 7:22 PM | marketbeat.comJ. L. Bainbridge & Co. Inc. Decreases Stock Position in Johnson & Johnson (NYSE:JNJ)J. L. Bainbridge & Co. Inc. trimmed its stake in shares of Johnson & Johnson (NYSE:JNJ - Free Report) by 4.4% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 157,625 shares of the company's stock afterMay 31 at 3:30 PM | marketbeat.comJohnson & Johnson (NYSE:JNJ) Stock Price Up 0.9%Johnson & Johnson (NYSE:JNJ) Shares Up 0.9%May 31 at 11:23 AM | seekingalpha.comJohnson & Johnson: Market Will Regret The OverreactionMay 31 at 11:00 AM | investorplace.comBoring Is Beautiful: 3 Blue-Chip Stocks to Buy and Hold ForeverMay 31 at 8:45 AM | businesswire.comJohnson & Johnson Completes Acquisition of Shockwave MedicalMay 30 at 5:59 PM | marketbeat.comTFO Wealth Partners LLC Purchases 13,348 Shares of Johnson & Johnson (NYSE:JNJ)TFO Wealth Partners LLC lifted its position in Johnson & Johnson (NYSE:JNJ - Free Report) by 2,557.1% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 13,870 shares of the company's stock after acquiring an additional 13,348 shaMay 30 at 2:45 PM | cnbc.comHealthy Returns: Pfizer, Merck, J&J and more to release cancer drug data at industry conferenceMay 30 at 1:46 PM | marketbeat.comJohnson & Johnson (NYSE:JNJ) Trading 0.2% Higher Johnson & Johnson (NYSE:JNJ) Shares Up 0.2%May 30 at 9:31 AM | fool.com3 Stocks That Could Be Easy Wealth BuildersMay 30 at 9:18 AM | marketbeat.comJohnson & Johnson (NYSE:JNJ) Coverage Initiated by Analysts at The Goldman Sachs GroupThe Goldman Sachs Group initiated coverage on Johnson & Johnson in a research note on Thursday. They set a "neutral" rating and a $160.00 target price for the company.May 30 at 12:22 AM | marketbeat.comJohnson & Johnson (NYSE:JNJ) Shares Acquired by Comgest Global Investors S.A.S.Comgest Global Investors S.A.S. raised its stake in Johnson & Johnson (NYSE:JNJ - Free Report) by 0.3% during the fourth quarter, according to its most recent disclosure with the SEC. The fund owned 1,816,614 shares of the company's stock after buying an additional 5,585 shares during the quarter.May 29 at 6:05 PM | theglobeandmail.comJohnson & Johnson’s experimental drug eases depression, insomnia symptoms in late-stage studyMay 29 at 6:05 PM | msn.comJohnson & Johnson's Drug Seltorexant Aces Late-Stage Depression TrialMay 29 at 5:48 PM | prnewswire.comSarepta Therapeutics Set to Join S&P MidCap 400May 29 at 4:36 PM | seekingalpha.comJohnson & Johnson (JNJ) Bernstein's 40th Annual Strategic Decisions Conference - (Transcript)May 29 at 2:31 PM | marketbeat.comJohnson & Johnson (NYSE:JNJ) Trading 0.1% Higher Johnson & Johnson (NYSE:JNJ) Trading 0.1% HigherMay 29 at 12:54 PM | finance.yahoo.comJohnson & Johnson (NYSE:JNJ) Stock's Been Sliding But Fundamentals Look Decent: Will The Market Correct The Share Price In The Future?May 29 at 8:12 AM | reuters.comJ&J's treatment for depression succeeds in late stage studyMay 29 at 6:00 AM | americanbankingnews.comJohnson & Johnson (NYSE:JNJ) Trading Down 1.8%May 28, 2024 | marketbeat.comJohnson & Johnson (NYSE:JNJ) Shares Sold by Legacy Advisors LLCLegacy Advisors LLC reduced its holdings in shares of Johnson & Johnson (NYSE:JNJ - Free Report) by 10.2% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 65,202 shares of the company's stock after selliMay 28, 2024 | msn.comM&A News: JNJ Snaps Up Ezcema Drug Maker Yellow Jersey for $1.25BMay 28, 2024 | finance.yahoo.comJohnson & Johnson Agrees to Buy Numab Unit, Investigational Skin Disease Treatment For $1.25 BillionMay 28, 2024 | finance.yahoo.comSector Update: Health Care Stocks Retreat Tuesday AfternoonMay 28, 2024 | investorplace.comHealthTech Heroes: 3 Medical Technology Stocks to Buy Before They BoomMay 28, 2024 | marketbeat.comJohnson & Johnson (NYSE:JNJ) Shares Down 1.1% Johnson & Johnson (NYSE:JNJ) Shares Down 1.1%May 28, 2024 | markets.businessinsider.comJohnson & Johnson To Acquire Rights To Numab Therapeutics' Clinical-Stage Bispecific Antibody NM26May 28, 2024 | reuters.comJ&J acquires rights to skin disorder drug for $1.25 blnMay 28, 2024 | globenewswire.comNumab Therapeutics Announces Johnson & Johnson to Acquire its Wholly-Owned Subsidiary Yellow Jersey Therapeutics Including Rights to NM26, a Bi-Specific Antibody for the Treatment of Atopic DermatitisMay 28, 2024 | businesswire.comJohnson & Johnson to Obtain Rights to a Clinical-Stage Bispecific Antibody to Address Distinct Patient Needs in Atopic DermatitisMay 28, 2024 | marketbeat.comJohnson & Johnson (NYSE:JNJ) Shares Acquired by Pine Valley Investments Ltd Liability CoPine Valley Investments Ltd Liability Co boosted its position in Johnson & Johnson (NYSE:JNJ - Free Report) by 9.2% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 102,847 shares of the company's stock aMay 27, 2024 | investorplace.com7 Dividend Stocks That Could Soar After Q1 Earnings ReportsMay 26, 2024 | marketbeat.comCantor Fitzgerald Investment Advisors L.P. Takes Position in Johnson & Johnson (NYSE:JNJ)Cantor Fitzgerald Investment Advisors L.P. purchased a new stake in shares of Johnson & Johnson (NYSE:JNJ - Free Report) in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm purchased 142,535 shares of the company's stock, valued atMay 26, 2024 | americanbankingnews.comJohnson & Johnson (NYSE:JNJ) Stock Price Down 0.8%May 25, 2024 | marketbeat.comNomura Asset Management Co. Ltd. Buys 61,445 Shares of Johnson & Johnson (NYSE:JNJ)Nomura Asset Management Co. Ltd. grew its stake in Johnson & Johnson (NYSE:JNJ - Free Report) by 4.6% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 1,383,338 shares of the company's stock after acquiring aMay 25, 2024 | investorplace.com3 Dow Stocks to Buy on the Dip: May 2024May 24, 2024 | marketbeat.comJohnson & Johnson (NYSE:JNJ) Shares Down 0.8% Johnson & Johnson (NYSE:JNJ) Shares Down 0.8%May 24, 2024 | investorplace.com3 Stocks to Safeguard Your Investments During a Market MeltdownMay 24, 2024 | marketbeat.comCommerce Bank Sells 13,951 Shares of Johnson & Johnson (NYSE:JNJ)Commerce Bank decreased its position in Johnson & Johnson (NYSE:JNJ - Free Report) by 1.2% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 1,116,462 shares of the company's stock after selliMay 24, 2024 | markets.businessinsider.comOptimistic Buy Rating for JNJ’s Tremfya Based on Strong Market Penetration Potential in IBDMay 24, 2024 | msn.comCancer victims file class action against Johnson & Johnson over ‘fraudulent’ bankruptciesMay 24, 2024 | nypost.comCancer victims file class action against Johnson & Johnson over ‘fraudulent' bankruptciesMay 23, 2024 | marketbeat.comZhang Financial LLC Sells 15,502 Shares of Johnson & Johnson (NYSE:JNJ)Zhang Financial LLC decreased its holdings in Johnson & Johnson (NYSE:JNJ - Free Report) by 59.2% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 10,695 shares of the company's stock after seMay 23, 2024 | seekingalpha.comJohnson & Johnson: Vital Signs Decent, A Compelling Value CaseMay 23, 2024 | americanbankingnews.comJohnson & Johnson (NYSE:JNJ) Receives "Outperform" Rating from Royal Bank of CanadaMay 22, 2024 | marketbeat.comV Square Quantitative Management LLC Purchases 9,807 Shares of Johnson & Johnson (NYSE:JNJ)V Square Quantitative Management LLC increased its stake in shares of Johnson & Johnson (NYSE:JNJ - Free Report) by 29.6% in the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 42,924 shares of the company's stMay 22, 2024 | reuters.comCancer victims sue Johnson & Johnson over 'fraudulent' bankruptcies Get Johnson & Johnson News Delivered to You Automatically Sign up to receive the latest news and ratings for JNJ and its competitors with MarketBeat's FREE daily newsletter. Email Address The #1 Crypto That You Don’t Own… Yet (Ad)There’s all kinds of “signals” to follow when investing in cryptos. But there’s one signal you should pay attention to above all others: Venture capital firms. You want to follow venture capital money into cryptocurrencies before anyone gets word of what’s happening. Click here for all the details… JNJ Media Mentions By Week JNJ Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. JNJ News Sentiment▼0.520.79▲Average Medical News Sentiment JNJ News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. JNJ Articles This Week▼3929▲JNJ Articles Average Week Get Johnson & Johnson News Delivered to You Automatically Sign up to receive the latest news and ratings for JNJ and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Eli Lilly and Company News Today Merck & Co., Inc. News Today AbbVie News Today Pfizer News Today Bristol-Myers Squibb News Today Zoetis News Today Royalty Pharma News Today Jazz Pharmaceuticals News Today Perrigo News Today Corcept Therapeutics News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:JNJ) was last updated on 6/1/2024 by MarketBeat.com Staff From Our PartnersThe #1 Crypto That You Don’t Own… YetCrypto 101 MediaBiden Nomination CANCELED?The Freeport SocietyClaim Your Complimentary Bitcoin RewardCrypto Swap ProfitsTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProDems have chosen Biden replacement?Paradigm PressShocking: One AI startup's revenue could surge 4,735%Manward PressMust-See: Elon’s New Invention is Absolutely InsaneInvestorPlaceNvidia is about to pass AppleWeiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Johnson & Johnson Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
